Molecular profiles of small cell lung cancer subtypes: therapeutic implications

Small cell lung cancer (SCLC; accounting for approximately 13%–15% of all lung cancers) is an exceptionally lethal malignancy characterized by rapid doubling time and high propensity to metastasize. In contrast to the increasingly personalized therapies in other types of lung cancer, SCLC is still r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Schwendenwein, Anna, Megyesfalvi, Zsolt, Barany, Nandor, Valko, Zsuzsanna, Bugyik, Edina, Lang, Christian, Ferencz, Bence, Paku, Sandor, Lantos, Andras, Fillinger, Janos, Rezeli, Melinda, Marko-Varga, Gyorgy, Bogos, Krisztina, Galffy, Gabriella, Renyi-Vamos, Ferenc, Hoda, Mir Alireza, Klepetko, Walter, Hoetzenecker, Konrad, Laszlo, Viktoria, Dome, Balazs
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7917449/
https://ncbi.nlm.nih.gov/pubmed/33718595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.02.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados